Literature DB >> 3902424

Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: research or clinical practice?

R A Rizza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3902424     DOI： 10.2337/diacare.8.5.511

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents.

Authors:  M Krempf; T Godeau; S Ranganathan; P Blanchard; P Ritz; B Charbonnel
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents.

Authors:  S Stenman; P H Groop; C Saloranta; K J Tötterman; F Fyhrqvist; L Groop
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

3.  Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas.

Authors:  P H Wang; F Beguinot; R J Smith
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.